DURHAM, N.C., March 12 /PRNewswire/ -- Cato Research Ltd., a global contract research and development organization, today announced that it has named John Cline as its new President.
Mr. Cline comes to Cato Research from etrials Worldwide (Nasdaq: ETWC), where he most recently served as President and CEO. Mr. Cline has over 25 years' experience in the pharmaceutical industry, including senior sales and marketing roles at Organon Inc., Caremark, a division of Baxter, and MiniDoc AB, a publicly held Swedish corporation. Mr. Cline also served as President, CEO and director of Expidata Inc., which was acquired by etrials in 2000, at which time he became President, CEO, and a member of the Board of Directors of etrials.
"John Cline brings extensive leadership experience to Cato Research," said Allen Cato, M.D., Ph.D., CEO of Cato Research. "His industry skills and vision for helping pharmaceutical and biotechnology companies bring new drugs to market efficiently and cost-effectively complement the strategic direction and unique business model Lynda Sutton and I have charted for Cato Research. We have known John for many years and we are delighted to welcome him to our organization. We look forward to his leadership and his contributions to our growing business."
About Cato Research Ltd.
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, Cato Research is a privately owned, full-service, global contract research organization providing strategic and tactical support for companies in the pharmaceutical, biotechnology, medical device, and medical diagnostic industries. With a staff of more than 300 employees located in the United States, Europe, Canada, Israel, and South Africa, Cato Research's services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. For more information, please visit our website at http://www.cato.com.
|SOURCE Cato Research Ltd.|
Copyright©2008 PR Newswire.
All rights reserved